Uses of Meyerclas

Meyerclas medicine contains the main ingredient is Tadalafil 20mg and other excipients just enough provided by the manufacturer. The drug is prepared in the form of film-coated tablets, packing box of 1 blister, each blister contains 1 tablet or 2 tablets.
Actions of Tadalafil:
Tadalafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (Cgmp) particularly of phosphodiesterase type 5 (PDE5). When sexual stimulation leads to local release of nitric oxide, inhibition of PDE5 by the active ingredient increases the concentration of GMP in the corpus cavernosum. Relaxes smooth muscle and increases blood flow into the penile tissue, thereby helping to achieve an erection. In the absence of sexual stimulation, this active ingredient has no effect.

What does Meyerclas do? Meyerclas drug is indicated for the treatment of the following cases:
Cases of erectile dysfunction. The drug is only effective when sexually stimulated. There are no indications for use in women. On the other hand, Meyerclas drug is contraindicated in the following cases:
Allergy to active ingredient Tadalafil or other excipients in the composition of the drug. The patient has a heart attack. Patient has unstable angina. Severe heart failure. Arrhythmia, low blood pressure, or unresponsive hypertension. The patient has a cerebrovascular accident.

Meyerclas drug is prepared in the form of film-coated tablets, for oral use. The drug should be taken at least 30 minutes before sexual intercourse.
The following is the recommended dose of Meyerclas:
The usual dose is 10mg, this dose can be increased to 20mg or reduced to 5mg as needed. The drug has a lasting effect up to 36 hours after taking it. The maximum recommended dose is once a day and should not be used continuously every day, because there are insufficient data on the safety of the drug in long-term use. Elderly people take Meyerclas drug at the same dose as normal people, no dose adjustment is required. Patients with hepatic impairment: The dose for patients with mild to moderate hepatic impairment should not exceed 10mg/day. Meyerclas should not be used in patients with severe liver failure. Patients with renal impairment: In patients with moderate renal impairment (creatinine clearance 31 to 50 mL/min), a starting dose of 5 mg should be initiated, not more than once daily, with a maximum dose not to exceed 10 mg per day. times every 48 hours. In patients with severe renal impairment (creatinine clearance less than 30 ml/min) including patients on hemodialysis, the maximum dose should not exceed 5 mg once daily. In patients stabilized on an alpha-blocker regimen, Meyerclas should be initiated at a dose of 5 mg. Patients taking strong inhibitors of the cytochrome P450 isoenzyme CYP3A4, should not take more than 10 mg once every 72 hours.

The doctor always considers the benefit that Meyerclas brings to the patient and the possible risk of side effects to prescribe the appropriate medication.
Some possible side effects when taking Meyerclas are as follows:
Common:
Headache, indigestion, nausea, dry mouth, back pain, muscle pain. Uncommon:
Eyelid swelling, eye pain, conjunctival congestion, nasal congestion, facial flushing, pain in the limbs, angina, hypotension, myocardial infarction, tachycardia, palpitations. Patients need to follow the doctor's prescription and when there are other symptoms of Meyerclas drug side effects, please inform your doctor or pharmacist.

Tell your doctor about all the medicines you are taking such as prescription drugs, over-the-counter medicines, dietary supplements, herbs... to limit possible interactions when taking the combination of these drugs. drugs during treatment.
Patients need to be aware of the following drug interactions:
Some protease inhibitors such as Ritonavir, Saquinavir and other CYP3A4 inhibitors such as Erythromycin, Clarithromycin, Itraconazole and grape juice when used concurrently with Meyerclas drugs need to be cautious, because they can increase the plasma concentration of the drug, and at the same time increase the unwanted effects of the drug. Meyerclas increases the bioavailability of oral Ethinyl Estradiol, with similar results for oral terbutaline. Drugs that induce cytochrome P450 (eg, Rifampin, Carbamazepine, Phenytoin, Phenobarbital) decrease drug concentrations.

Some notes when using Meyerclas drug are as follows:
Caution when used in patients with liver failure, severe renal failure, patients with pathologies that easily cause penile erection pain or patients with positive anatomical deformities. object. The drug should not be used in patients with spinal cord injury and in patients with hereditary problems of galactose intolerance. Check the patient's cardiovascular condition before using this medicine. Patients with congenital retinopathy including retinitis pigmentosa should not use this drug. If the patient experiences penile pain for more than 4 hours, the doctor should be informed. The safety and effectiveness of the combination of Meyerclas and other erectile dysfunction drugs have not been evaluated, so the combination of these drugs should not be used unless directed by your doctor. Above is information about uses, dosage and precautions when using Meyerclas medicine. To ensure safety for your health and maximize the effectiveness of your treatment, you need to take Meyerclas exactly as directed by your doctor.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.